The prototypical ICIs for lung cancer, also known as programmed death protein 1 (PD-1), and its ligand, programmed cell death ligand 1 (PD-L1) and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), are the most studied ICI targets. The gene discussed is CTLA4; the disease is lung carcinoma.